Methyl (4,6-diaMino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyriMidin-5-yl)(Methyl)carbaMate
98 %
- Product Code: 51919
CAS:
625115-55-1
| Molecular Weight: | 422.4 g./mol | Molecular Formula: | C₂₀H₁₉FN₈O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or active ingredient in the development of therapeutic agents, particularly targeting specific enzymes or receptors involved in disease pathways. Its structural features make it suitable for applications in designing inhibitors for kinase-related disorders, such as cancer or inflammatory conditions. Additionally, it may be explored for its potential in central nervous system (CNS) drug development due to its pyrazole and pyrimidine moieties, which are often associated with neuroactive properties. Research efforts focus on optimizing its pharmacokinetic and pharmacodynamic properties to enhance efficacy and reduce toxicity in clinical applications.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 97.5 100% |
| Appearance | Yellow powder |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | Ft24,564.97 |
+
-
|
| 0.500 | 10-20 days | Ft79,405.18 |
+
-
|
Methyl (4,6-diaMino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyriMidin-5-yl)(Methyl)carbaMate
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or active ingredient in the development of therapeutic agents, particularly targeting specific enzymes or receptors involved in disease pathways. Its structural features make it suitable for applications in designing inhibitors for kinase-related disorders, such as cancer or inflammatory conditions. Additionally, it may be explored for its potential in central nervous system (CNS) drug development due to its pyrazole and pyrimidine moieties, which are often associated with neuroactive properties. Research efforts focus on optimizing its pharmacokinetic and pharmacodynamic properties to enhance efficacy and reduce toxicity in clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :